AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Drug: mometasone furoate
Target: Glucocorticoid receptor (Nuclear hormone receptor)
Gene: NR3C1
UniProt: P04150 (GCR_HUMAN)
Organism: Homo sapiens
Activity: Ki = 9.15
Action type: AGONIST
Assay: Inhibition of glucocorticoid receptor (unknown origin)
Drug: mometasone furoate
Target: Progesterone receptor (Nuclear hormone receptor)
Gene: PGR
UniProt: P06401 (PRGR_HUMAN)
Organism: Homo sapiens
Activity: EC50 = 9.9
Drug: monobenzone
Target: Prostaglandin G/H synthase 2 (Enzyme)
Gene: PTGS2
UniProt: P35354 (PGH2_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 5.429
Assay: DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid)
Drug: monobenzone
Target: Prostaglandin G/H synthase 1 (Enzyme)
Gene: PTGS1
UniProt: P23219 (PGH1_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 5.992
Assay: DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid)
Drug: monobenzone
Target: Sodium-dependent noradrenaline transporter (Transporter)
Gene: SLC6A2
UniProt: P23975 (SC6A2_HUMAN)
Organism: Homo sapiens
Activity: Ki = 5.414
Assay: DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55)
Drug: monobenzone
Target: Tyrosinase (Enzyme)
Gene: TYR
UniProt: P14679 (TYRO_HUMAN)
Organism: Homo sapiens
Action type: INHIBITOR
Assay: Mechanism of Action; CHEMBL1973; SINGLE PROTEIN
Drug: monobenzone
Target: Arachidonate 15-lipoxygenase (Enzyme)
Gene: ALOX15
UniProt: P12530 (LOX15_RABIT)
Organism: Oryctolagus cuniculus
Activity: IC50 = 5.311
Assay: DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid)
Drug: montelukast
Target: Beta-2 adrenergic receptor (GPCR)
Gene: ADRB2
UniProt: P07550 (ADRB2_HUMAN)
Organism: Homo sapiens
Activity: Ki = 5.62
Assay: DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)
Drug: montelukast
Target: Alpha-2A adrenergic receptor (GPCR)
Gene: ADRA2A
UniProt: P08913 (ADA2A_HUMAN)
Organism: Homo sapiens
Activity: Ki = 5.833
Assay: DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug: montelukast
Target: Sodium-dependent noradrenaline transporter (Transporter)
Gene: SLC6A2
UniProt: P23975 (SC6A2_HUMAN)
Organism: Homo sapiens
Activity: Ki = 5.574
Assay: DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55)
Drug: montelukast
Target: 5-hydroxytryptamine receptor 2B (GPCR)
Gene: HTR2B
UniProt: P41595 (5HT2B_HUMAN)
Organism: Homo sapiens
Activity: Ki = 5.4
Assay: DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide)
Drug: montelukast
Target: D(3) dopamine receptor (GPCR)
Gene: DRD3
UniProt: P35462 (DRD3_HUMAN)
Organism: Homo sapiens
Activity: Ki = 5.58
Assay: DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone)
Drug: montelukast
Target: Muscarinic acetylcholine receptor M1 (GPCR)
Gene: CHRM1
UniProt: P11229 (ACM1_HUMAN)
Organism: Homo sapiens
Activity: Ki = 5.713
Assay: DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine)
Drug: montelukast
Target: Muscarinic acetylcholine receptor M3 (GPCR)
Gene: CHRM3
UniProt: P20309 (ACM3_HUMAN)
Organism: Homo sapiens
Activity: Ki = 5.853
Assay: DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine)
Drug: montelukast
Target: Beta-3 adrenergic receptor (GPCR)
Gene: ADRB3
UniProt: P13945 (ADRB3_HUMAN)
Organism: Homo sapiens
Activity: Ki = 5.495
Assay: DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol)
Drug: montelukast
Target: Alpha-2C adrenergic receptor (GPCR)
Gene: ADRA2C
UniProt: P18825 (ADA2C_HUMAN)
Organism: Homo sapiens
Activity: Ki = 6.115
Assay: DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912)
Drug: montelukast
Target: Sodium-dependent dopamine transporter (Transporter)
Gene: SLC6A3
UniProt: Q01959 (SC6A3_HUMAN)
Organism: Homo sapiens
Activity: Ki = 5.685
Assay: DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55)
Drug: montelukast
Target: Adenosine receptor A3 (GPCR)
Gene: ADORA3
UniProt: P0DMS8 (AA3R_HUMAN)
Organism: Homo sapiens
Activity: Ki = 6.611
Assay: DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)
Drug: montelukast
Target: Cytochrome P450 2C8 (Enzyme)
Gene: CYP2C8
UniProt: P10632 (CP2C8_HUMAN)
Organism: Homo sapiens
Activity: Ki = 5.958
Drug: montelukast
Target: Delta-type opioid receptor (GPCR)
Gene: OPRD1
UniProt: P41143 (OPRD_HUMAN)
Organism: Homo sapiens
Activity: Ki = 5.772
Assay: DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole)
Drug: montelukast
Target: Cysteinyl leukotriene receptor 1 (GPCR)
Gene: CYSLTR1
UniProt: Q9Y271 (CLTR1_HUMAN)
Organism: Homo sapiens
Activity: Ki = 9.3
Action type: ANTAGONIST
Assay: GRAC: human CysLT1 selective antagonist
Drug: montelukast
Target: Arachidonate 5-lipoxygenase (Enzyme)
Gene: ALOX5
UniProt: P09917 (LOX5_HUMAN)
Organism: Homo sapiens
Activity: Ki = 4.328
Drug: montelukast
Target: Epidermal growth factor receptor (Kinase)
Gene: EGFR
UniProt: P00533 (EGFR_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 5.495
Assay: DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))
Drug: montelukast
Target: Tyrosine-protein kinase Fyn (Kinase)
Gene: FYN
UniProt: P06241 (FYN_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 5.328
Assay: DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))
Drug: montelukast
Target: Thromboxane-A synthase (Enzyme)
Gene: TBXAS1
UniProt: P24557 (THAS_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 5.817
Assay: DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2)
Drug: montelukast
Target: Cysteinyl leukotriene receptor 2 (GPCR)
Gene: CYSLTR2
UniProt: Q9NS75 (CLTR2_HUMAN)
Organism: Homo sapiens
Activity: Ki  5.301
Drug: montelukast
Target: Mitogen-activated protein kinase 14 (Kinase)
Gene: MAPK14
UniProt: Q16539 (MK14_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 6.068
Assay: DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)
Drug: montelukast
Target: Substance-K receptor (GPCR)
Gene: TACR2
UniProt: P21452 (NK2R_HUMAN)
Organism: Homo sapiens
Activity: Ki = 5.895
Assay: DRUGMATRIX: Tachykinin NK2  radioligand binding (ligand: [3H] SR-48968)
Drug: montelukast
Target: Cysteinyl leukotriene receptor 1 (GPCR)
Gene: CYSLTR1
UniProt: Q2NNR5 (CLTR1_CAVPO)
Organism: Cavia porcellus
Activity: Ki = 9.3
Assay: Binding affinity towards Cysteinyl leukotriene D4 receptor (cysLT1) was measured by the displacement of [3H]LTD4 radioligand
Drug: montelukast
Target: Uracil nucleotide/cysteinyl leukotriene receptor (GPCR)
Gene: GPR17
UniProt: Q13304 (GPR17_HUMAN)
Organism: Homo sapiens
Activity: Ki = 5.18
Assay: Displacement of [3H]PSB-12150 from human GPR17 expressed in CHO-K1 cell membranes after 60 mins by heterologous competition binding assay
Drug: montelukast
Target: Uracil nucleotide/cysteinyl leukotriene receptor (GPCR)
Gene: Gpr17
UniProt: Q6NS65 (GPR17_MOUSE)
Organism: Mus musculus
Activity: IC50 = 7.21
Action type: ANTAGONIST
Drug: moperone
Target: D(2) dopamine receptor (GPCR)
Gene: DRD2
UniProt: P14416 (DRD2_HUMAN)
Organism: Homo sapiens
Activity: Ki = 9
Drug: moperone
Target: D(3) dopamine receptor (GPCR)
Gene: DRD3
UniProt: P35462 (DRD3_HUMAN)
Organism: Homo sapiens
Activity: Ki = 9.5
Drug: moperone
Target: D(4) dopamine receptor (GPCR)
Gene: DRD4
UniProt: P21917 (DRD4_HUMAN)
Organism: Homo sapiens
Activity: Ki = 8.134
Drug: moracizine
Target: Sodium channel protein type 5 subunit alpha (Ion channel)
Gene: SCN5A
UniProt: Q14524 (SCN5A_HUMAN)
Organism: Homo sapiens
Action type: BLOCKER
Drug: morphine
Target: Mu-type opioid receptor (GPCR)
Gene: OPRM1
UniProt: P35372 (OPRM_HUMAN)
Organism: Homo sapiens
Activity: EC50 = 7.86
Action type: AGONIST
Drug: morphine
Target: Kappa-type opioid receptor (GPCR)
Gene: OPRK1
UniProt: P41145 (OPRK_HUMAN)
Organism: Homo sapiens
Activity: Ki = 6.97
Drug: morphine
Target: Delta-type opioid receptor (GPCR)
Gene: OPRD1
UniProt: P41143 (OPRD_HUMAN)
Organism: Homo sapiens
Activity: Ki = 6.62
Drug: morphine
Target: Solute carrier family 22 member 1 (Transporter)
Gene: SLC22A1
UniProt: O15245 (S22A1_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 4.55
Assay: Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy
Drug: morphine
Target: Mu-type opioid receptor (GPCR)
Gene: Oprm1
UniProt: P33535 (OPRM_RAT)
Organism: Rattus norvegicus
Activity: Ki = 9.11
Assay: mu-1 receptor binding affinity in rat brain by 3H [d-Ala2, d-Leu5] enkephalin displacement.
Drug: morphine
Target: Mu-type opioid receptor (GPCR)
Gene: Oprm1
UniProt: P42866 (OPRM_MOUSE)
Organism: Mus musculus
Activity: Ki = 8.92
Assay: Displacement of [3H]DAMGO from mu opioid receptor in CD1 mouse brain membranes after 1 hr by liquid scintillation counting
Drug: morphine
Target: Mu-type opioid receptor (GPCR)
Gene: OPRM1
UniProt: P97266 (OPRM_CAVPO)
Organism: Cavia porcellus
Activity: Ki = 9.06
Assay: Binding affinity towards Opioid receptor mu 1 of guinea pig brain membranes using radioligand 0.25 nM [3H]DAMGO
Drug: morphine
Target: Delta-type opioid receptor (GPCR)
Gene: Oprd1
UniProt: P32300 (OPRD_MOUSE)
Organism: Mus musculus
Activity: Ki = 7
Assay: Displacement of [3H]DPDPE from delta opioid receptor in CD1 mouse brain membranes after 1 hr by liquid scintillation counting
Drug: morphine
Target: Delta-type opioid receptor (GPCR)
Gene: Oprd1
UniProt: P33533 (OPRD_RAT)
Organism: Rattus norvegicus
Activity: Ki = 8.74
Assay: Displacement of [3H]DPDPE from delta opioid receptor in rat brain membranes
Drug: morphine
Target: Kappa-type opioid receptor (GPCR)
Gene: OPRK1
UniProt: P41144 (OPRK_CAVPO)
Organism: Cavia porcellus
Activity: Ki = 7.62
Assay: Binding affinity towards guinea pig Opioid receptor kappa 1 using radioligand [3H]U-69593
Drug: morphine
Target: Kappa-type opioid receptor (GPCR)
Gene: Oprk1
UniProt: P34975 (OPRK_RAT)
Organism: Rattus norvegicus
Activity: Ki = 7.57
Assay: Inhibition of 9 (2 nM) binding to Opioid receptor kappa 1 of rat brain homogenate
Drug: morphine
Target: Kappa-type opioid receptor (GPCR)
Gene: Oprk1
UniProt: P33534 (OPRK_MOUSE)
Organism: Mus musculus
Activity: Ki = 6.52
Assay: Evaluated for the binding affinity at kappa receptor
Drug: morphine
Target: Mu-type opioid receptor (GPCR)
Gene: OPRM1
UniProt: P79350 (OPRM_BOVIN)
Organism: Bos taurus
Activity: Ki = 9.3
Assay: Binding affinity towards opioid receptor mu 1
Drug: morphine
Target: Nociceptin receptor (GPCR)
Gene: OPRL1
UniProt: P47748 (OPRX_CAVPO)
Organism: Cavia porcellus
Activity: Ki = 7.86
Assay: Displacement of radiolabeled NalBzOH from kappa3 opioid receptor in Hartley guinea pig brain
Drug: morphine
Target: Opioid receptor (GPCR)
Gene: Oprd1|Oprm1|Oprk1|Sigmar1
UniProt: P33533|P33535|P34975|Q9R0C9 (OPRD_RAT|OPRM_RAT|OPRK_RAT|SGMR1_RAT)
Organism: Rattus norvegicus
Activity: Ki = 8.22
Assay: Inhibition of [3H]- naloxone binding to Opioid receptors in rat brain membrane in the absence of Na
Drug: morphine
Target: Dopamine receptor (GPCR)
Gene: Drd1|Drd3|Drd5|Drd4|Drd2
UniProt: P18901|P19020|P25115|P30729|P61169 (DRD1_RAT|DRD3_RAT|DRD5_RAT|DRD4_RAT|DRD2_RAT)
Organism: Rattus norvegicus
Activity: IC50 = 8.27
Assay: Concentration inhibiting the specific binding of [3H]naloxone by 50% in the absence of NaCl
Drug: morphine
Target: Opioid receptor (GPCR)
Gene: Sigmar1|Oprd1|Oprk1|Oprm1
UniProt: O55242|P32300|P33534|P42866 (SGMR1_MOUSE|OPRD_MOUSE|OPRK_MOUSE|OPRM_MOUSE)
Organism: Mus musculus
Activity: IC50 = 7.57
Assay: Concentration required to inhibit [3H]naltrexone binding to Opioid receptors
Drug: morphine
Target: Mu opioid receptor-like OR2 (GPCR)
Gene: oprm1
UniProt: Q98UH1 (Q98UH1_DANRE)
Organism: Danio rerio
Activity: Ki = 6.73
Drug: morphine
Target: Opioid receptor, delta 1b (GPCR)
Gene: oprd1b
UniProt: B3DH72 (B3DH72_DANRE)
Organism: Danio rerio
Activity: Ki = 5.85
Assay: Displacement of [3H]DPN from zebrafish delta 1b opioid receptor expressed in HEK293 cell membranes after 4 hrs by scintillation counting method
Drug: morphine
Target: Opioid receptor homologue (GPCR)
Gene: oprd1a
UniProt: O57585 (O57585_DANRE)
Organism: Danio rerio
Activity: Ki = 6.65
Assay: Displacement of [3H]DPN from zebrafish delta 1a opioid receptor expressed in HEK293 cell membranes after 1 hr by scintillation counting method
Drug: mosapramine
Target: D(4) dopamine receptor (GPCR)
Gene: DRD4
UniProt: P21917 (DRD4_HUMAN)
Organism: Homo sapiens
Activity: Ki = 10.52
Assay: Agonist activity at dopamine D4 receptor (unknown origin)
Drug: mosapride
Target: 5-hydroxytryptamine receptor 4 (GPCR)
Gene: HTR4
UniProt: O70528 (5HT4R_CAVPO)
Organism: Cavia porcellus
Activity: Ki = 7.16
Assay: Inhibition of [3H]GR-113808 binding to guinea pig striatum 5-hydroxytryptamine 4 receptor
Drug: mosapride
Target: Alpha-2A adrenergic receptor (GPCR)
Gene: ADRA2A
UniProt: P08913 (ADA2A_HUMAN)
Organism: Homo sapiens
Activity: Ki = 5.86
Assay: DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug: mosapride
Target: Sigma non-opioid intracellular receptor 1 (Membrane receptor)
Gene: SIGMAR1
UniProt: Q99720 (SGMR1_HUMAN)
Organism: Homo sapiens
Activity: Ki = 6.891
Assay: DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol)
Drug: mosapride
Target: Potassium voltage-gated channel subfamily H member 2 (Ion channel)
Gene: KCNH2
UniProt: Q12809 (KCNH2_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 5.32
Assay: Inhibition of human ERG expressed in HEK293 cells by whole cell patch clamp method
Drug: mosapride
Target: Cytochrome P450 3A4 (Enzyme)
Gene: CYP3A4
UniProt: P08684 (CP3A4_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 6.155
Assay: DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)
Drug: mosapride
Target: Sodium-dependent serotonin transporter (Transporter)
Gene: SLC6A4
UniProt: P31645 (SC6A4_HUMAN)
Organism: Homo sapiens
Activity: Ki = 5.694
Assay: DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)
Drug: mosapride
Target: 5-hydroxytryptamine receptor 2B (GPCR)
Gene: HTR2B
UniProt: P41595 (5HT2B_HUMAN)
Organism: Homo sapiens
Activity: Ki = 6.725
Assay: DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide)
Drug: mosapride
Target: 5-hydroxytryptamine receptor 2C (GPCR)
Gene: HTR2C
UniProt: P28335 (5HT2C_HUMAN)
Organism: Homo sapiens
Activity: Ki = 6.683
Assay: DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine)
Drug: mosapride
Target: Alpha-2B adrenergic receptor (GPCR)
Gene: ADRA2B
UniProt: P18089 (ADA2B_HUMAN)
Organism: Homo sapiens
Activity: Ki = 6.06
Assay: DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug: mosapride
Target: 5-hydroxytryptamine receptor 3A (Ion channel)
Gene: HTR3A
UniProt: P46098 (5HT3A_HUMAN)
Organism: Homo sapiens
Activity: Ki = 5.7
Drug: mosapride
Target: Cytochrome P450 2C9 (Enzyme)
Gene: CYP2C9
UniProt: P11712 (CP2C9_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 6
Assay: DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)
Drug: mosapride
Target: Cytochrome P450 1A2 (Enzyme)
Gene: CYP1A2
UniProt: P05177 (CP1A2_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 6.398
Assay: DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)
Drug: mosapride
Target: Cytochrome P450 2C19 (Enzyme)
Gene: CYP2C19
UniProt: P33261 (CP2CJ_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 6
Assay: DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)
Drug: mosapride
Target: Serotonin 3 (5-HT3) receptor (Ion channel)
Gene: Htr3a|Htr3b
UniProt: P35563|Q9JJ16 (5HT3A_RAT|5HT3B_RAT)
Organism: Rattus norvegicus
Activity: Ki = 5.92
Assay: Inhibition of [3H]GR-65630 binding to rat cortical membrane serotonin 5-hydroxytryptamine 3 receptor
Drug: mosapride
Target: 5-hydroxytryptamine receptor 4 (GPCR)
Gene: HTR4
UniProt: Q13639 (5HT4R_HUMAN)
Organism: Homo sapiens
Activity: Ki = 6.9
Action type: AGONIST
Drug: latamoxef
Target: Peptidoglycan synthase FtsI (Enzyme)
Gene: ftsI
UniProt: P0AD68 (FTSI_ECOLI)
Organism: Escherichia coli (strain K12)
Activity: IC50 = 5.938
Action type: INHIBITOR
Drug: latamoxef
Target: Penicillin-binding protein 1A (Enzyme)
Gene: mrcA
UniProt: P02918 (PBPA_ECOLI)
Organism: Escherichia coli (strain K12)
Activity: IC50 = 6.716
Action type: INHIBITOR
Drug: latamoxef
Target: Penicillin-binding protein 1B (Enzyme)
Gene: mrcB
UniProt: P02919 (PBPB_ECOLI)
Organism: Escherichia coli (strain K12)
Activity: IC50 = 4.637
Action type: INHIBITOR
Drug: moxastine
Target: Histamine H1 receptor (GPCR)
Gene: HRH1
UniProt: P35367 (HRH1_HUMAN)
Organism: Homo sapiens
Action type: ANTAGONIST
Assay: Mechanism of Action
Drug: moxifloxacin
Target: DNA topoisomerase 4 subunit A (Enzyme)
Gene: parC
UniProt: P0C1U9 (PARC_STAAU)
Organism: Staphylococcus aureus
Activity: IC50 = 6.1
Assay: Inhibitory activity against Staphylococcus aureus ATCC 29213 wild type Topo 4
Drug: moxifloxacin
Target: DNA gyrase subunit A (Enzyme)
Gene: gyrA
UniProt: P9WG47 (GYRA_MYCTU)
Organism: Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
Activity: IC50 = 5.04
Assay: Inhibition of DNA supercoiling activity of wild type Mycobacterium tuberculosis DNA gyrase A
Drug: moxifloxacin
Target: Topoisomerase IV (Enzyme)
Gene: parC|parE
UniProt: P0AFI2|P20083 (PARC_ECOLI|PARE_ECOLI)
Organism: Escherichia coli (strain K12)
Action type: INHIBITOR
Assay: Mechanism of Action; CHEMBL2363076; PROTEIN COMPLEX
Drug: moxifloxacin
Target: DNA gyrase (Enzyme)
Gene: gyrA|gyrB
UniProt: P0AES4|P0AES6 (GYRA_ECOLI|GYRB_ECOLI)
Organism: Escherichia coli (strain K12)
Activity: IC50 = 6.52
Action type: INHIBITOR
Assay: Inhibitory activity against wild type Escherichia coli gyrase
Drug: moxonidine
Target: Alpha-2A adrenergic receptor (GPCR)
Gene: ADRA2A
UniProt: P08913 (ADA2A_HUMAN)
Organism: Homo sapiens
Activity: Ki = 6.82
Assay: Binding affinity for human Alpha-2A adrenergic receptor
Drug: moxonidine
Target: 5-hydroxytryptamine receptor 1A (GPCR)
Gene: HTR1A
UniProt: P08908 (5HT1A_HUMAN)
Organism: Homo sapiens
Activity: Ki = 6.397
Assay: DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT)
Drug: moxonidine
Target: Alpha-2C adrenergic receptor (GPCR)
Gene: ADRA2C
UniProt: P18825 (ADA2C_HUMAN)
Organism: Homo sapiens
Activity: Ki = 5.7
Assay: Binding affinity for human Alpha-2C adrenergic receptor
Drug: moxonidine
Target: Alpha-2B adrenergic receptor (GPCR)
Gene: Adra2b
UniProt: P19328 (ADA2B_RAT)
Organism: Rattus norvegicus
Activity: Ki = 6
Assay: Binding affinity for rat Alpha-2B adrenergic receptor
Drug: moxonidine
Target: 5-hydroxytryptamine receptor 1A (GPCR)
Gene: Htr1a
UniProt: P19327 (5HT1A_RAT)
Organism: Rattus norvegicus
Activity: IC50 = 6.15
Drug: moxonidine
Target: Nischarin (Unclassified)
Gene: Nisch
UniProt: Q4G017 (NISCH_RAT)
Organism: Rattus norvegicus
Activity: Ki = 7.11
Drug: moxonidine
Target: Nischarin (Membrane receptor)
Gene: NISCH
UniProt: Q9Y2I1 (NISCH_HUMAN)
Organism: Homo sapiens
Activity: Ki = 8.38
Action type: AGONIST
Assay: Displacement of [125I]PIC from human imidazoline receptor 1 in human platelets analyzed under norepinephrine mask of alpha 2AR
Drug: mupirocin
Target: Isoleucine--tRNA ligase (Enzyme)
Gene: ileS
UniProt: P00956 (SYI_ECOLI)
Organism: Escherichia coli (strain K12)
Activity: Ki = 8.6
Assay: Competitive inhibition of Escherichia coli Isoleucyl-tRNA synthetase
Drug: mupirocin
Target: Isoleucine--tRNA ligase, cytoplasmic (Enzyme)
Gene: IARS
UniProt: P41252 (SYIC_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 9.1
Assay: Compound was evaluated for inhibitory activity against Isoleucyl-tRNA synthetase
Drug: mupirocin
Target: Isoleucine--tRNA ligase (Enzyme)
Gene: ileS
UniProt: P41972 (SYI1_STAAU)
Organism: Staphylococcus aureus
Action type: INHIBITOR
Drug: mupirocin
Target: Isoleucine--tRNA ligase (Enzyme)
Gene: ileS
UniProt: Q99YW3 (SYI_STRP1)
Organism: Streptococcus pyogenes serotype M1
Action type: INHIBITOR
Assay: Mechanism of Action; CHEMBL2364671; SINGLE PROTEIN
Drug: mupirocin
Target: Isoleucine--tRNA ligase (Enzyme)
Gene: ileS
UniProt: P56690 (SYI_THET8)
Organism: Thermus thermophilus
Activity: Ki = 7.22
Assay: Inhibition of recombinant Thermus thermophilus HB8 IleRS L583F mutant assessed as suppression of L-[14C]isoleucyl-tRNA(Ile) formation
Drug: mycophenolate mofetil
Target: Inosine-5'-monophosphate dehydrogenase 1 (Enzyme)
Gene: IMPDH1
UniProt: P20839 (IMDH1_HUMAN)
Organism: Homo sapiens
Activity: Ki = 7.481
Action type: INHIBITOR
Drug: mycophenolate mofetil
Target: Inosine-5'-monophosphate dehydrogenase 2 (Enzyme)
Gene: IMPDH2
UniProt: P12268 (IMDH2_HUMAN)
Organism: Homo sapiens
Activity: Ki = 8.155
Action type: INHIBITOR
Drug: mycophenolic acid
Target: Inosine-5'-monophosphate dehydrogenase 1 (Enzyme)
Gene: IMPDH1
UniProt: P20839 (IMDH1_HUMAN)
Organism: Homo sapiens
Activity: Ki = 7.48
Assay: Inhibitory activity against human Inosine-5'-monophosphate dehydrogenase 1 (IMPDH type I isoform); Range is 33-37 nM
Drug: mycophenolic acid
Target: Inosine-5'-monophosphate dehydrogenase 2 (Enzyme)
Gene: IMPDH2
UniProt: P12268 (IMDH2_HUMAN)
Organism: Homo sapiens
Activity: Ki = 8.22
Assay: Inhibitory activity against human Inosine-5'-monophosphate dehydrogenase 2 (IMPDH type II isoform); Range is 6-10 nM
Drug: mycophenolic acid
Target: Inosine-5'-monophosphate dehydrogenase (IMPDH) (Enzyme)
Gene: IMPDH2|IMPDH1
UniProt: P12268|P20839 (IMDH2_HUMAN|IMDH1_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 4.7
Action type: INHIBITOR
Assay: Inhibitory activity against (IMPDH) inosine 5'-monophosphate dehydrogenase
Drug: mycophenolic acid
Target: Inosine-5'-monophosphate dehydrogenase (Unclassified)
UniProt: Q5KP44 (IMDH_CRYNJ)
Organism: Cryptococcus neoformans var. neoformans serotype D
Activity: IC50 = 6.92
Assay: Inhibition of recombinant Cryptococcus neoformans His-tagged IMPDH expressed in Escherichia coli BL21 (DE3) using IMP as substrate in presence of NAD
Drug: nabilone
Target: Cannabinoid receptor 1 (GPCR)
Gene: CNR1
UniProt: P21554 (CNR1_HUMAN)
Organism: Homo sapiens
Activity: Ki = 8.4
Action type: AGONIST
Assay: Displacement of [3H]-CP55940 from human CB1 receptor expressed in CHO cells by liquid scintillation counting
Drug: nabilone
Target: Cannabinoid receptor 2 (GPCR)
Gene: CNR2
UniProt: P34972 (CNR2_HUMAN)
Organism: Homo sapiens
Activity: Ki = 8.2
Assay: Displacement of [3H]-CP55940 from human CB2 receptor expressed in CHO cells by liquid scintillation counting
Drug: nabilone
Target: Cannabinoid receptor 1 (GPCR)
Gene: Cnr1
UniProt: P20272 (CNR1_RAT)
Organism: Rattus norvegicus
Activity: Ki = 8.66
Drug: nabilone
Target: Cannabinoid receptor 2 (GPCR)
Gene: Cnr2
UniProt: P47936 (CNR2_MOUSE)
Organism: Mus musculus
Activity: Ki = 8.74
Drug: nabumetone
Target: Prostaglandin G/H synthase 2 (Enzyme)
Gene: PTGS2
UniProt: P35354 (PGH2_HUMAN)
Organism: Homo sapiens
Action type: INHIBITOR
Assay: Mechanism of Action; CHEMBL230; SINGLE PROTEIN
Drug: nabumetone
Target: Prostaglandin G/H synthase 1 (Enzyme)
Gene: PTGS1
UniProt: P23219 (PGH1_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 3.34
Drug: nabumetone
Target: Sodium-dependent noradrenaline transporter (Transporter)
Gene: SLC6A2
UniProt: P23975 (SC6A2_HUMAN)
Organism: Homo sapiens
Activity: Ki = 5.732
Assay: DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55)
Drug: nabumetone
Target: Cytochrome P450 1A2 (Enzyme)
Gene: CYP1A2
UniProt: P05177 (CP1A2_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 5.301
Assay: DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)
Drug: nabumetone
Target: Amine oxidase [flavin-containing] A (Enzyme)
Gene: MAOA
UniProt: P21397 (AOFA_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 6.001
Assay: DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine)
Drug: nadolol
Target: Beta-1 adrenergic receptor (GPCR)
Gene: ADRB1
UniProt: P08588 (ADRB1_HUMAN)
Organism: Homo sapiens
Activity: Ki = 6.9
Action type: ANTAGONIST
Drug: nadolol
Target: Beta-2 adrenergic receptor (GPCR)
Gene: ADRB2
UniProt: P07550 (ADRB2_HUMAN)
Organism: Homo sapiens
Activity: Ki = 8.6
Action type: ANTAGONIST